Accuray Incorporated (ARAY) vs Elutia Inc. (ELUT)

Accuray Incorporated and Elutia Inc. are both Medical Devices companies. Elutia Inc. is the larger, with a market value of $36.8M against $27.8M — 1.3× the size. Accuray Incorporated has negative trailing earnings, so its P/E is not meaningful; Elutia Inc. trades at 0.7×. Elutia Inc. grew revenue faster over the last twelve months: 69.0% against −12.3%. Elutia Inc. has the higher net margin (488.2% vs −12.2%) and the higher return on invested capital (0.00% vs −11.3%). Across the 18 metrics below, Accuray Incorporated leads on 9 and Elutia Inc. on 9.

Valuation

Metric ARAY ELUT Medical Devices median
P/E n/m 0.67 22.18
P/S 0.07 2.99 2.70
P/B 0.65 2.30 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA n/m n/m 11.78
EV/Sales 0.33 3.50 2.38
Earnings yield (181.82%) 150.00% (8.22%)
Free cash flow yield (47.85%) (126.92%) (7.80%)

Profitability

Metric ARAY ELUT Medical Devices median
Gross margin 27.73% 57.76% 56.01%
Operating margin (6.58%) (214.85%) (15.03%)
Net margin (12.24%) 488.15% (20.40%)
Free cash flow margin (3.19%) (379.26%) (7.24%)
Return on equity (80.08%) (454.01%) (15.32%)
Return on assets (10.77%) 152.89% (19.72%)
Return on invested capital (11.25%) 0.00% (10.33%)

Growth

Metric ARAY ELUT Medical Devices median
Revenue growth (TTM) (12.34%) 69.03% 8.80%
EPS growth (last fiscal year) (2,480.65%) 146.77% —
Revenue growth, 5-year CAGR 0.28% (22.04%) 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARAY ELUT Medical Devices median
Debt to equity 3.51 0.00 0.07
Current ratio 1.50 1.77 2.50
Net debt to EBITDA (10.10) 1.51 0.49

Dividend

Metric ARAY ELUT Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric ARAY ELUT Medical Devices median
Market cap 27.82m 36.76m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack